Laparoscopic splenectomy's effect on liver function in cirrhosis patients
Official title: The Effect of Laparoscopic Splenectomy on Liver Reserve Function for Cirrhosis Patients
Run by Northern Jiangsu People's Hospital · NCT05325424 · Data updated 2026-11-12
This study tests if a minimally invasive surgery to remove the spleen can improve liver function in patients with cirrhosis.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Northern Jiangsu People's Hospital Academic / other |
| Locations | 1 site (Yangzhou, Jiangsu) |
| Status | Recruiting |
| Started | March 1, 2022 |
| Main results expected | July 31, 2025 |
| Study ends | July 31, 2025 |
| Registry record updated | May 30, 2025 |
| Trial ID | NCT05325424 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include patients with cirrhosis and splenomegaly who have a platelet count below 50*10^9/L.
✕Probably not a fit
Patients with advanced liver disease (Child-Pugh grade C), malignancies, or other serious health conditions may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the impact of laparoscopic splenectomy on liver reserve function in patients diagnosed with cirrhosis. Participants undergo the surgical procedure, and their liver function indicators are monitored at multiple time points post-surgery. The goal is to determine if this surgical intervention can enhance liver function and improve overall patient prognosis. A standardized treatment and follow-up plan is implemented to ensure consistency in patient care.
Why it matters
Potential benefit: If successful, this approach could significantly improve liver function and quality of life for patients with cirrhosis.
How similar studies have gone: While similar studies have explored the effects of splenectomy on liver function, this specific approach and its outcomes in cirrhosis patients are relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * A clinical, radiological or histologic diagnosis of cirrhosis of any etiology * Splenomegaly with secondary hypersplenism, Platelet count \< 50\*10\^9/L * Informed consent to participate in the study Exclusion Criteria: * Hepatocellular carcinoma or any other malignancy, * Child-Pugh grade C * Recent peptic ulcer disease * History of Hemorrhagic stroke * Pregnancy. * Uncontrolled Hypertension * Bleeding portal hypertension * Human immunodeficiency virus (HIV) infection
Where it's running
-
Clinical Medical College of Yangzhou University
Yangzhou, Jiangsu, China Recruiting
Study contacts
- Study coordinator: Guo-Qing Jiang, MD
- Email: jgqing2003@hotmail.com
- Phone: +8651487373272
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Education to prevent infections after spleen removal
See if a targeted educational program for adults who had their spleen removed improves vaccination uptake, awareness of infection risk, and continuity of care.
-
Laparoscopic surgery to improve immune function in cirrhosis patients
This study is testing if a specific type of surgery can help boost the immune system in people with liver cirrhosis who have an enlarged spleen.
-
Surgery to improve liver function in cirrhosis patients
This study tests whether a specific surgery can help improve liver function in patients with cirrhosis who have an enlarged spleen.
-
Italian questionnaire to measure knowledge and vaccination attitudes in people without a spleen
This project will test a new Italian questionnaire to measure how much people without a spleen know about infection prevention and vaccination.
-
Laparoscopic partial removal of the spleen for hypersplenism in cirrhosis.
This test tries whether removing part of the spleen by laparoscopy improves immune function and recovery in people with cirrhosis and hypersplenism.
-
Vaccination for patients without a spleen
This study is testing if the meningococcal B vaccine is safe and effective for people who don’t have a spleen compared to healthy individuals.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.